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The dystonias are a common but complex group of disorders that show considerable variation in cause
and clinical presentation. The purpose of this review is to highlight the most important discoveries and
insights from across the field over the period of the past 18 months.
Recent findings
Five new genes for primary dystonia (PRRT2, CIZ1, ANO3, TUBB4A and GNAL) have made their
appearance in the literature. New subtypes of neuronal brain iron accumulation have been delineated
and linked to mutations in C19orf12 and WDR45, while a new treatable form of dystonia with brain
manganese deposition related to mutations in SLC30A10 has been described. At the same time, the
phenotypes of other forms of dystonic syndromes have been expanded or linked together. Finally, there
has been increasing recognition of both the extramotor phenotype in dystonia and the part played by the
cerebellum in its pathophysiology.
Summary
Recently, there has been unprecedented change in the scientific landscape with respect to the cause of
various dystonic syndromes that is likely to make a direct impact on clinical practice in the near future.
Understanding the genetic cause of these syndromes and the often wide phenotypic variation in their
presentations will improve diagnosis and treatment. With time, these discoveries may also lead to
much-needed progress in elucidating the underlying pathophysiology of dystonia.
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The dystonias are a heterogenous group of
hyperkinetic movement disorders, characterized
by involuntary sustained muscle contractions
affecting one or more sites of the body that lead
to twisting and repetitive movements or abnormal
postures of the affected body part. They represent
the third most common movement disorder world-
wide [1–4]. There are currently 23 DYT loci referring
to primary dystonic syndromes, as well as a number
of primary dystonic syndromes not currently
assigned to any DYT loci (see Table 1). In addition,
there are numerous heredodegenerative disorders in
the context of which dystonia is commonly seen.
Recent advances in the field of dystonia have
mirrored to a considerable degree advances in genetic
technology. Fuelled by the increasing use of whole-
exome sequencing approaches, researchers have been
able to elucidate the genetic cause of various familial
forms of dystonia at an unprecedented rate. In doing
so, several new dystonic syndromes have come into
existence, whereas other long-recognized dystoniciams & Wilkins. Unauthosyndromes have been linked either to novel or
occasionally even well-known genes. These dis-
coveries are addressed in the following sections.PAROXYSMAL KINESIGENIC
DYSKINESIA: PRRT2 AND PHENOTYPIC
HETEROGENEITY
Paroxysmal kinesigenic dyskinesia (PKD), which
is also known as DYT10, is a form of primaryrized reproduction of this article is prohibited.
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KEY POINTS
 The past 2 years have seen considerable change in the
field of dystonia driven predominantly by rapid
advances in genetic sequencing technologies.
 Five new genes for primary dystonia have appeared in
the literature (PRRT2, CIZ1, ANO3, TUBB4A and
GNAL).
 Two new forms of neuronal brain iron accumulation and
a potentially treatable form of generalized dystonia with
brain manganese deposition are also now known.
 Pathophysiological understanding continues to lag
behind, but increasing emphasis recently on dystonia
as a network disease, involving brain areas beyond the
basal ganglia, is an important step forward.
Table 1. The current DYT loci (after removal of withdra
phenotype, mode of inheritance and genetic cause or linka
Locus
symbol
Gene or linkage interval
(wherever known) Phenotype
DYT1 TOR1A Early-onset primary torsion
populations
DYT2 Not known Early-onset primary dyston
and generalization
DYT3 TAF1 Adult-onset dystonia-parkin
DYT4 TUBB4A Whispering dysphonia wit
alcohol sensitivity
DYT5a GCH1 Progressive dopa-responsiv
affecting the lower limbs
DYT5b TH Akinetic rigid syndrome w
encephalopathy
DYT6 THAP1 Adult-onset torsion dystonia
laryngeal involvement a
DYT7 18p Adult-onset primary cervica
DYT8 MR-1 Paroxysmal nonkinesigenic
chocolate and stress
DYT10 PRRT2 Paroxysmal kinesigenic dy
including epilepsy, migr
DYT11 SGCE Myoclonic dystonia, often
manifestations
DYT12 ATP1A3 Rapid-onset dystonia parki
DYT13 1p36.32–p36.13 Early-onset torsion dystonia
DYT15 18p11 Myoclonic dystonia with a
kindred only
DYT16 PRKRA Early-onset dystonia-parkin
DYT17 20p11.2–q13.12 Primary focal dystonia with
DYT18 SLC2A1 Paroxysmal exercise-induc
such as epilepsy, haemo
DYT20 2q31 Paroxysmal nonkinesiogen
family only
DYT21 2q14.3–q21.3 Adult-onset mixed dystonia
DYT23 ANO3 Autosomal dominant, often
limb tremor
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1350-7540  2013 Wolters Kluwer Health | Lippincott Williams & Wilkdystonia with a prevalence of about one in 150000
individuals [5]. It is characterized by frequent (up to
100 times a day) attacks of dystonic or choreiform
movements lasting from a few seconds to a few
minutes. In late 2011, mutations in PRRT2 (pro-
line-rich transmembrane protein 2) were identified
as the cause of PKD in nearly all cases [6,7].
Most mutations are truncating and by far the most
common of these is the c.649dupC mutation,
but missense variants (possibly with reduced
penetrance) have also been described [8–11]. Inter-
estingly, the c.649dupC mutation was also found
in the family used to define DYT19, a supposedly
separate form of PKD, suggesting that the initial
linkage in this family was incorrect and DYT19
is in fact synonymous with DYT10 [12].thorized reproduction of this article is prohibited.
wn, duplicate and unpublished loci) with associated
ge interval, wherever known
Mode of
inheritance
dystonia with high prevalence in Jewish AD
ia with prominent craniocervical involvement AR
sonism, prevalent in the Philippines X-linked
h generalization, ’hobby horse’ gait and AD
e dystonia with diurnal variation often AD




l dystonia with questionable linkage AD
dyskinesia with attacks induced by alcohol, AD
skinesia with wide phenotypic variability,
aine and intermittent torticollis
AD
with alcohol responsiveness, and psychiatric AD
nsonism or alternating hemiplegia of childhood AD/de novo
in one Italian family only AD
lcohol responsiveness in one Canadian AD
sonism with a rostocaudal gradient AR
progression in one Lebanese family only AR
ed dyskinesia with or without other features,
lytic anaemia or spastic paraparesis
AD
ic dyskinesia 2, in one large Canadian AD
with generalization in one Swedish family only AD
tremulous craniocervical dystonia þ/ upper AD
ins www.co-neurology.com 407
CMovement disordersThe gene encodes a protein which is highly
expressed throughout the nervous system. On a
cellular level, it appears that the PRRT2 protein
is predominantly localized to the synapse and
that it may participate in neurotransmitter release,
suggesting disrupted neurotransmission as the
possible pathological mechanism in PKD [13].
Most interesting of all, perhaps, has been the
recognition that mutations in this gene also cause
a number of other paroxysmal disorders. In fact,
PRRT2-related disease appears to be a stunning
example of the kind of phenotypic heterogeneity
often encountered in genetic forms of dystonia,
with clinical presentation differing not merely
between individuals carrying different mutations,
but also between individuals carrying the same
mutation and even between affected members
within the same family [14]. Two forms of child-
hood epilepsy, namely, infantile convulsions with
choreoathetosis (ICCA) and benign familial infan-
tile seizures, as well as episodic ataxia, hemiplegic
migraine and benign paroxysmal torticollis of
infancy are all now recognized as possible manifes-
tations of mutations in this gene [12,15–17].EXPANDING PHENOTYPES IN DYSTONIA
In a similar fashion to PRRT2, the phenotype of
mutations in ATP1A3 has recently been revised to
include what was previously considered a separate
condition. Mutations in this gene are traditionally
associated with rapid onset dystonia-parkinsonism.
In the last fewmonths, however, it has become clear
that ATP1A3 mutations are also responsible for
a neuropaediatric condition labelled alternating





a rare disorder characterized by the onset before the
age of 18 months of paroxysmal neurological
events, such as hemiplegia alternating in laterality,
quadriplegia, dystonic spells, oculomotor abnor-
malities and autonomic dysfunction, all of which
abate during sleep [20]. Nonparoxysmal manifes-
tations develop after a few months or years of the
disease, comprising developmental delay, intellec-
tual disability of variable degree, ataxia, dysarthria,
choreoathetosis, and, in some patients, pyramidal
tract signs. Two separate studies were able to
demonstrate de-novo heterozygous mutations in
ATP1A3 as the cause of the disorder in 75–100%





Meanwhile, the phenotypic spectrum of muta-
tions in SGCE, which causes myoclonus dystonia,
has also been revised to reflect an increased aware-
ness of psychiatric manifestations of the disease.
One recent study systematically assessed 27 SGCE
mutation carriers using a battery of standardizedopyright © Lippincott Williams & Wilkins. Unautho
408 www.co-neurology.compsychiatric interviews and questionnaires and
compared them with a disability-matched control
group of patients with alcohol-responsive tremor
[21
&
]. Obsessive–compulsive disorder was eight
times more likely and generalized anxiety disorder
and alcohol dependence five times more likely in
SGCEmutation carriers than in the tremor controls.
This well designed study indicates that SGCE muta-
tions are associated with a specific psychiatric
phenotype consisting of compulsivity, anxiety




Finally, primary dystonia itself has undergone a
phenotypic expansion of sorts in light of growing
evidence indicating an important nonmotor com-
ponent to the condition, including abnormalities in
sensory and perceptual functions as well as neuro-
psychiatric, cognitive and sleep domains. These
additional features may help explain the fact that
reduction in quality of life in dystonia does not
always correlate with the extent of themotor deficit.
Moreover, it may be possible to capitalize on some
of these extramotor signs – impaired temporal
discrimination thresholds, for instance – to detect
nonmanifesting mutation carriers in familial forms
of dystonia, which would greatly facilitate the
identification of new genes wherein establishing
segregation is key. Interested readers are directed
to a recent review by Stamelou et al. [22
&
] and the
paper by Kimmich et al. [23].FOUR NEW GENES FOR PRIMARY PURE
DYSTONIA
In 2012, four new genes have been reported to
cause primary pure dystonia, in which dystonia is
the sole manifestation with the exception of tremor
(see Table 2). Most studies used to identify the new
genes have employed a whole-exome sequencing
approach combined with linkage analysis to tackle
smaller kindreds than was previously possible.
The first gene to appear on the scene was CIZ1.
A missense mutation in this gene was published
as the likely cause of focal, adult-onset cervical
dystonia, variably associated with mild tremor,
which was inherited as an autosomal dominant trait
with reduced penetrance [24
&
]. The age of onset
in the index family was quite wide, ranging from
18 to 66 years, but generalization was not observed.
Screening in a cohort of patients with adult-onset
dystonia identified two additional missense muta-
tions in three individuals, all with focal cervical
dystonia developing in mid-to-late life [24
&
]. How-
ever, segregation analysis was not possible in any of
these additional cases, somewhat compromising the
level of genetic evidence for this gene. In addition,rized reproduction of this article is prohibited.
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Table 2. Summary of the four new forms of primary pure dystonia identified in the last year
Gene name Implicated mechanism
Typical age at








CIZ1 Cell cycle regulation and
DNA replication












No generalization Prominent head,
voice or arm tremor
TUBB4A
(DYT4)













Adolescence to mid-life Craniocervical Generalization in
about 10%
Hyposmia?
Dystonic syndromes: an update Charlesworth and Bhatiaothers have raised questions regarding the quality
and coverage of the exome data, meaning it will
be particularly important to await independent
confirmation of mutations in this gene before it
can be fully accepted as a definite cause of dystonia
[25]. The protein encoded by CIZ1 is a p21Cip1/Waf1-
interacting zinc finger protein that is expressed
in the brain and involved in DNA synthesis and
cell-cycle control [26].
Mutations in a second gene, ANO3, were
identified as the cause of autosomal dominant
craniocervical dystonia in a moderately sized white
kindred [27
&&
]. Subsequent screening of the whole
gene in a cohort of 188 individuals with cervical
dystonia revealed five further novel of variants, of
which segregation could be demonstrated for two.
Clinically, patients with mutations in this gene
exhibited focal or segmental dystonia, variably
affecting the craniocervical, laryngeal or brachial
regions. There was often dystonic tremor with a
jerky quality affecting the head, voice or upper
limbs. The age at onset ranged from the very early
childhood to 40 years of age. As with CIZ1, the
dystonia was never seen to generalize in any affected
individual, remaining confined to the head, neck
and upper limbs. Indeed, some individuals with
mutations in this gene manifested upper limb
tremor alone and had been misclassified as essential
tremor [27
&&
]. Little is known about the function of
ANO3, but it ismost highly expressed in the striatum
and is thought to encode a Ca2þ-activated chloride
channel [27
&&
,28]. Such channels are believed
to have a role to play in modulating neuronal
excitability, suggesting a possible mechanism by
which altered channel function could lead to
aberrant neuronal excitability manifest as dystonic
movements [29].Copyright © Lippincott Williams & Wilkins. Unau
1350-7540  2013 Wolters Kluwer Health | Lippincott Williams & WilkTUBB4A has recently been identified by two
groups independently as the cause of DYT4 dysto-





The condition was first described by forensic
psychiatrist Neville Parker [32] in a large family
with third decade onset of autosomal dominantly
inherited laryngeal dystonia with generalization.
Over 25 affected individuals have since been
reported, with some exhibiting a distinctive ‘hobby
horse’ gait [33]. Alcohol responsiveness is not
uncommon, leading to severe alcohol abuse in some
DYT4 patients [33]. To date, however, no other
family with this characteristic phenotype has been
described, suggesting that the condition is very
rare. TUBB4A encodes b-tubulin-4a, a constituent
of microtubules, and the mutation in this family
(p.Arg2Gly) results in an arginine to glycine amino-
acid substitution in the key, highly conserved auto-
regulatory MREI (methionine–arginine–glutamic
acid–isoleucine) domain of the protein. One further
novel variant in this gene (p.Ala271Thr) was
detected in an individual exhibiting spasmodic
dysphonia with oromandibular dystonia and dys-
kinesia with an age at onset of 60 [30
&
]. However,
segregation analysis was not possible, meaning the
pathogenicity of the variant is uncertain.
Finally, mutations in GNAL have recently been
identified as a cause of autosomal dominant primary





]. Initially, it appeared that GNAL
may have been an exceptionally common cause
of familial dystonia with the first group reporting
that six out of only 39 families screened (15%)
haboured mutations in this gene [34
&&
]. However,
the second group found only three mutations in
760 individuals screened (<0.5%), which is perhaps
more in line with what might be expected [35
&
].thorized reproduction of this article is prohibited.
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CMovement disordersRegardless, clinical characterization of individuals
carrying mutations in GNAL showed a strong
cervical predilection, with 82% having onset in
the region of the neck and 93% displaying cervical
involvement by the time theywere examined for the
study in question. However, progression to other
sites had occurred in at least half of those affected
and generalized dystonia was seen in about 10%
of cases [34
&&
]. Thus, the clinical phenotype in
GNAL-related dystonia appears to be not dissimilar
to that caused by mutations in THAP1. The gene is
highly expressed in the olfactory epithelium and
hyposmia was noted in some affected individuals,
though not consistently [35
&
]. GNAL encodes Gaolf,
the alpha subunit of triheteromeric G protein Golf,
which is involved in dopamine (D1) signalling [36].
As D1 receptors have a known role in mediating
locomotor activity, the link between GNAL and
dystonia is biologically plausible.A NEW WILSON’S DISEASE?
Recently, the first inborn error of manganese
metabolism has been identified, clinically resembling
Wilson’s disease. Biallelic mutations in the gene
SLC30A10, which encodes amanganese transporter,
were shown to be the cause of a syndrome that
consisted of early-onset generalized dystonia, liver





]. Serum manganese levels are generally in
the range 1000–6000nmol/l (normal <320) and
MRI of the brain typically shows hyperintensities
in the basal ganglia as well as the subthalamic and
dentate nuclei. Over 20 affected individuals from
10 different families have been described by two
separate groups.
As with Wilson’s disease, the disorder appears
at least partially treatable. Using a combination
of ethylenediaminetetraacetic acid and ferrous
fumarate, clinicians were able to reduce serum
manganese and induce improvement in dystonia
in patients with this condition [39]. Again, as with
Wilson’s disease, early introduction of treatment
is likely to be key so that evaluation of serum
manganese may also take its place alongside copper
and caeruloplasmin studies as one of the few
obligatory investigations in young-onset dystonia
of unexplained cause.NEW FORMS OF NEURODEGENERATION
WITH BRAIN IRON ACCUMULATION
Neurodegeneration with brain iron accumulation
(NBIA) results from excessive iron deposition in the
brain, mainly the basal ganglia. Pantothenate kinase-
associated neurodegeneration (PKAN, NBIA1) andopyright © Lippincott Williams & Wilkins. Unautho
410 www.co-neurology.comPLA2G6-associated neurodegeneration (PLAN, NBIA2)
are the core syndromes, but several other less frequent
genetic causes have been identified (including FA2H,
ATP13A2, CP and FTL) [40]. Now, two further sub-
types have been identified and linked tomutations in
the genes C19orf12 and WDR45.
Mutations in C19orf12, an orphan mitochon-
drial protein, appear to be a relatively common
cause of NBIA, accounting for 23 of 161 idiopathic
cases (15%) screened by one group [41]. The
condition, dubbed mitochondrial membrane
protein-associated neurodegeneration or MPAN, is
characterized by cognitive decline progressing to
dementia, prominent neuropsychiatric abnormal-
ities and a motor neuronopathy [42]. Dystonia is
common (75%) and frequently affects the hands
and feet, although it is generalized in some. OnMRI,
the ’eye-of-the-tiger’ sign is absent, but iron
deposition is seen in the globus pallidus and the
substantia nigra. As with PLAN, cortical Lewy bodies
were present on neuropathological examination of
brain tissue from an affected individual [42].
WDR45 is located on the X chromosome and
encodes a beta-propeller scaffold protein with a
putative role in autophagy. In late 2012, mutations
in this gene were linked to a novel form of
NBIA, now known by the acronym SENDA (static
encephalopathy of childhood with neurodegenera-
tion in adulthood). SENDA is characterized by global
developmental delay in early childhood and slow
motor and cognitive gains until adolescence or early
adulthood, at which point dystonia, parkinsonism,




]. A unique feature
of this form of NBIA was reported to be T1 hyper-
intensity surrounding a central linear region of
signal hypointensity within the substantia nigra
and cerebral peduncles. From a genetic point of
view, the condition is interesting for at least two
reasons. First, all mutations occurred de novo such
that Mendelian inheritance was never observed.
Second, although WDR45 is located on the X
chromosome and undergoes inactivation, the
clinical features of this form of NBIA do not follow
a pattern typical of an X-linked disorder. Instead,
the phenotype of affected males is indistinguish-
able from that of females. It is thought that the
most likely explanation for this is that males
with germline mutations are nonviable and that
postzygotic mutations are instead responsible for




Accurately distinguishing psychogenic from non-
psychogenic, primary dystonia is essential if patientsrized reproduction of this article is prohibited.
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Dystonic syndromes: an update Charlesworth and Bhatiaare to receive the form of treatment that is
most likely to benefit them and progress is to be
made with regard to understanding the underlying
neurobiology. Two recent studies have sought
reliable markers to distinguish these conditions.
The first investigated cortical plasticity using
transcranial magnetic stimulation and the paired
associative stimulation protocol in patients with
psychogenic or organic dystonia and compared
them with healthy controls [45]. Whereas cortical
plasticity was increased in the group with organic
dystonia (as expected), it was normal in both
patients with psychogenic dystonia and healthy
controls. A second study used functional neuro-
imaging to investigate movement-related cerebral
activation in three groups, one with psychogenic
fixed dystonia, another with genetically deter-
mined organic dystonia and a third consisting
of healthy controls [46
&
]. In organic dystonia,
averaged regional cerebral blood flowwas increased
in the primary motor, premotor and parietal
cortices,whereas itwas decreased in the cerebellum.
In contrast, patients with psychogenic dystonia
displayed an opposite pattern of activation, with
increased regional blood flow in the cerebellum
and basal ganglia and decreased flow in the
primary motor cortex. Together these studies
suggest that distinct neurobiological mechanisms
underpin organic and psychogenic dystonia,
with the former related to aberrant motor cortical
plasticity and metabolism and the latter related
to abnormalities of frontosubcortical processing
[46
&
].THE RISING IMPORTANCE OF THE
CEREBELLUM IN DYSTONIA
In terms of our understanding of the patho-
physiology of dystonia, researchers have continued
to make slow but steady progress. One notable
trend in the last yearhas beena growing recognition
of the part played by the cerebellum in the dis-
order. Multiple convergent strands of evidence
from animal models, clinical observations, and
anatomical, imaging and electrophysiological
studies have highlighted the importance of the
cerebellum in dystonia. At present, it remains
unclear whether the cerebellar abnormalities
observed in some of these studies are secondary
(and perhaps compensatory) to basal ganglia
dysfunction or are, in some cases at least, the
driving force behind the development of dystonia.
A recent review by Sadnicka et al. [47
&
] of the
accumulating evidence in this area as well as
its implications is recommended to the interested
reader.Copyright © Lippincott Williams & Wilkins. Unau
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Fuelled by the rapid improvement in genetic
sequencing technologies, there has been an un-
precedented advance in our understanding of the
cause of several forms of primary and heredodege-
nerative dystonia. It is likely that the continued
improvement of these technologies – in particular
the introduction of inexpensive whole-genome
sequencing – will lead to further advances in
coming years. At present, many of the new genes
identified have yet to be independently confirmed
and their prevalence as a cause of dystonia is as yet
unclear. Nonetheless, an understanding of the
function of these new genes may help researchers
identify key pathways in the development of dysto-
nia that could form the targets of novel therapeutic
agents or interventions. Indeed, there remains an
urgent need to clarify the underlying pathophysio-
logy of the disorder, which is still poorly understood
despite considerable research and effort. This is
likely to be a difficult task given the apparent hetero-
geneity of causes in dystonia, but it is probable that
a shift away from the paradigm of dystonia as a
disorder of the basal ganglia alone towards one of
dystonia as the common manifestation of dysfunc-
tion at any one of a number of points in a complex
network of brain areas will prove an important step
in this process.
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